CNL Healthcare Properties, Inc.
CHTH
$3.00
-$0.50-14.29%
| Weiss Ratings | CHTH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | CHTH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Fair | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CHTH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -260.75 | |||
| Price History | CHTH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 67.23% | |||
| 30-Day Total Return | -10.71% | |||
| 60-Day Total Return | -15.49% | |||
| 90-Day Total Return | -25.00% | |||
| Year to Date Total Return | 7.14% | |||
| 1-Year Total Return | -25.93% | |||
| 2-Year Total Return | 1,100.00% | |||
| 3-Year Total Return | -34.78% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -26.83% | |||
| 52-Week Low % Change | 29,900.00% | |||
| Price | CHTH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $4.10 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Apr 04, 2024 | |||
| 52-Week High Price (Date) | Jul 11, 2024 | |||
| Valuation | CHTH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 521.83M | |||
| Enterprise Value | 1.05B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.09 | |||
| Earnings Per Share Growth | -39.40% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.43 | |||
| Price/Book (Q) | 0.73 | |||
| Enterprise Value/Revenue (TTM) | 2.86 | |||
| Price | $3.00 | |||
| Enterprise Value/EBITDA (TTM) | 12.81 | |||
| Enterprise Value/EBIT | 33.81 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | CHTH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 173.94M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -123.16% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CHTH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 407 650 1000 | |||
| Address | CNL Center at City Commons Orlando, FL 32801-3330 | |||
| Website | www.cnlhealthcareproperties.com | |||
| Country | United States | |||
| Year Founded | 2010 | |||
| Profitability | CHTH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 8.44% | |||
| Profit Margin | -3.95% | |||
| Management Effectiveness | CHTH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 1.44% | |||
| Return on Equity | -- | |||
| Income Statement | CHTH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 27.30M | |||
| Total Revenue (TTM) | 365.96M | |||
| Revenue Per Share | $2.10 | |||
| Gross Profit (TTM) | 90.36M | |||
| EBITDA (TTM) | 81.60M | |||
| EBIT (TTM) | 30.91M | |||
| Net Income (TTM) | -14.46M | |||
| Net Income Avl. to Common (TTM) | -14.46M | |||
| Total Revenue Growth (Q YOY) | 7.84% | |||
| Earnings Growth (Q YOY) | 45.61% | |||
| EPS Diluted (TTM) | -0.09 | |||
| EPS Diluted Growth (Q YOY) | 36.83% | |||
| Balance Sheet | CHTH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 44.01M | |||
| Cash Per Share (Q) | $0.25 | |||
| Total Current Assets (Q) | 45.61M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 711.78M | |||
| Current Ratio (Q) | 1.521 | |||
| Book Value Per Share (Q) | $4.09 | |||
| Total Assets (Q) | 1.32B | |||
| Total Current Liabilities (Q) | 29.99M | |||
| Total Debt (Q) | 567.21M | |||
| Total Liabilities (Q) | 607.56M | |||
| Total Common Equity (Q) | 711.78M | |||
| Cash Flow | CHTH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -16.14M | |||
| Cash from Financing (TTM) | -34.42M | |||
| Net Change in Cash (TTM) | -10.28M | |||
| Levered Free Cash Flow (TTM) | 53.61M | |||
| Cash from Operations (TTM) | 40.29M | |||
